Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings

Radiology

Volumn 250, Issue 1, 2009, Pages 193-201

  Lim, C C Tchoyoson ^a,g   Gan, Robert ^a   Chan, Cheng Leng ^b   Tan, Hons Alvin W K ^c   Khoo, Joan J C ^d   Chia, Su Ynn ^e   Kao, Shih Ling ^f   Abisheganaden, John ^c   Sitoh, Yih Yian ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b HEALTH SCIENCES AUTHORITY   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d CHANGI GENERAL HOSPITAL   (Singapore)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GLIBENCLAMIDE; ILLICIT DRUG; SILDENAFIL; ANTIDIABETIC AGENT; LACTIC ACID; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; STREET DRUG; SULFONE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN ANGIOGRAPHY; BRAIN BLOOD VOLUME; BRAIN CORTEX; CAPSULA INTERNA; CAUDATE NUCLEUS; CAUSE OF DEATH; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DRUG FORMULATION; DRUG OVERDOSE; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; IMAGING SYSTEM; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROIMAGING; NEUROPATHOLOGY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR; BLOOD VOLUME; BRAIN; CEREBROVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COMA; CONSCIOUSNESS DISORDER; DRUG CONTAMINATION; DRUG EFFECT; GLASGOW COMA SCALE; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SEIZURE;

ADULT; AGED; BLOOD VOLUME; BRAIN; CEREBROVASCULAR DISORDERS; COMA; CONSCIOUSNESS DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; DOMINANCE, CEREBRAL; DRUG CONTAMINATION; GLASGOW COMA SCALE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; LACTIC ACID; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHYTOTHERAPY; PIPERAZINES; PURINES; RETROSPECTIVE STUDIES; SEIZURES; STREET DRUGS; SULFONES; VASODILATOR AGENTS;

EID: 58149359588     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2493080795     Document Type: Article

References (47)

1. Ropper AH, Adams RD, Victor M, Brown RH, Victor M. The acquired metabolic disorders of the nervous system. In: Adams and Victor's principles of neurology. 8th ed. New York, NY: McGraw-Hill, 2005; 959-982.
2. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 1985;17:421-430.
3. Röther J, Schreiner A, Wentz KU, Hennerici M. Hypoglycemia presenting as basilar artery thrombosis. Stroke 1992;23:112-113.
4. Boeve BF, Bell DG, Noseworthy JH. Bilateral temporal lobe MRI changes in uncomplicated hypoglycaemic coma. Can J Neurol Sci 1995; 22:56-58.
5. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y. Specific changes in human brain after hypoglycaemic injury. Stroke 1997;28:584-587.
6. Finelli PF. Diffusion-weighted MR in hypo- glycaemic coma. Neurology 2001;57:933-935.
7. Garambois K, Grand S, Jaillard A, Hommel M. Diffusion-weighted magnetic resonance imaging in hypoglycaemic coma [in French]. Rev Neurol (Paris) 2004;160:575-578.
8. Shirayama H, Ohshiro Y, Kinjo Y, et al. Acute brain injury in hypoglycemia-induced hemiplegia. Diabet Med 2004;21:623-624.
9. Yanagawa Y, Isoi N, Tokumaru AM, Sakamoto T, Okada Y. Diffusion-weighted MRI predicts prognosis in severe hypoglycemic encephalopathy. J Clin Neurosci2006;13:696-699.
10. Jung SL, Kim BS, Lee KS, Yoon KH, Byun JY. Magnetic resonance imaging and diffusion-weighted imaging changes after hypoglycemic coma. J Neuroimaging 2005;15: 193-196.
11. Maekawa S, Aibiki M, Kikuchi K, Kikuchi S, Umakoshi K. Time related changes in reversible MRI findings after prolonged hypoglycemia. Clin Neurol Neurosurg 2006;108:511- 513.
12. Cho SJ, Minn YK, Kwon KH. Severe hypoglycemia and vulnerability of the brain. Arch Neurol 2006;63:138.
13. Aoki T, Sato T, Hasegawa K, Ishizaki R, Saiki M. Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycaemic coma. Neurology 2004;63:392-393.
14. Bottcher J, Kunze A, Kurrat C, et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia- induced hemiparesis. Stroke 2005;36:e20-e22.
15. Cordonnier C, Oppenheim C, Lamy C, Meder JF, Mas JL. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 2005;65:175.
16. Albayram S, Ozer H, Gokdemir S, et al. Reversible reduction ofapparent diffusion coefficient values in bilateral internal capsules in transient hypoglycemia-induced hemiparesis. AJNR Am J Neuroradiol 2006;27:1760- 1762.
17. Lo L, Tan CH, Umapathi T, Lim CC. Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol 2006;27:1222-1224.
18. Kim JH, Choi JY, Koh SB, Lee Y. Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology2007;49:217-222.
19. Maruya J, Endoh H, Watanabe H, Motoyama H, Abe H. Rapid improvement of diffusion-weighted imaging abnormalities after glucose infusion in hypoglycaemic coma. J Neurol Neurosurg Psychiatry 2007;78: 102-103.
20. Terakawa Y, Tsuyuguchi N, Nunomura K, et al. Reversible diffusion-weighted imaging changes in the splenium of the corpus callo- sum and internal capsule associated with hypoglycemia. Neurol Med Chir (Tokyo) 2007; 47:486-488.
21. HSA warns consumers against taking an illegal product "Power 1 Walnut." Health Sciences Authority of Singapore. http://www.hsa.gov.sg/ publish/hsaportal/en/news-events/press-releases/2008.-hsaArticleBody-77345- DownloadFile.tmp/PressRelease -HSAWarnsConsumersAgainstTakingAn IllegalPdtPower1Walnut-13Feb2008r2.pdf. Published February 13, 2008. Accessed May 5, 2008.
22. HSA updates investigation and findings on illegal product "Power1 Walnut." HealthSci- ences Authority of Singapore. http://www.hsa.gov.sg/ publish/hsaportal/en/news-events/press-releases/2008.-hsaArticleBody-93865- DownloadFile.tmp/PressRelease-HSAUpdatesInvestigations&FindingsOn IllegalPdtPower1Walnut-22Feb08.pdf. Published February 22, 2008. Accessed May 5, 2008.
23. HSA updates on first fatality associated with use of "Power 1 Walnut." Health Sciences Authority of Singapore. http://www.hsa.gov.sg/ publish/hsaportal/en/news-events/press-releases/2008.-hsaArticleBody-63857- DownloadFile.tmp/HSAPressRelease -HSAUpdatesOnFirstFatalityAssociated WithUseOfPower1Walnut-07Apr2008.pdf-releases/2008.-hsaArticleBody-26435- DownloadFile.tmp/PressRelease-HSA UpdatesonIllegalPdtPower1Walnut-7Mar 2008.pdf. Published April 7, 2008. Accessed 5 May 2008.
24. Yee SK, Chu SS, Xu YM, Choo PL. Regulatory control of Chinese proprietary medi cines in Singapore. Health Policy 2005;71: 133-149.
25. Auer RN, Wieloch T, Olsson Y, Siesjo BK. The distribution of hypoglycemic brain damage. Acta Neuropathol 1984;64:177-191.
26. Auer RN. Progress review: hypoglycaemic brain damage. Stroke 1986;17:699-708.
27. Auer RN, Siesjo BK. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 1988;24:699-707.
28. Auer RN, Hugh J, Cosgrove E, Curry B. Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 1989; 8:63- 68.
29. Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke 1996;27:1648-1656.
30. Le Bihan D. The "wet mind": water and functional neuroimaging. Phys Med Biol 2007;52: R57-R90.
31. Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001;221:43-50.
32. Tsuchiya K, Katase S, Yoshino A. Diffusion-weighted MR imaging of encephalitis. AJR Am J Roentgenol 1999;173:1097-1099.
33. Lim CC, Lee KE, Lee WL, et al. Nipah virus encephalitis: serial MR study in an emerging disease. Radiology 2002;222:219-226.
34. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021-1027.
35. Parmar H, Lim SH, Tan CK, Lim CC. Acute symptomatic seizures and hippocampus damage: DWI and MRS findings. Neurology 2006;66:1732-1735.
36. Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol 1997;54:1411-1415.
37. Lim CC, Tan K, Verma KK, Yin H, Venketasubramanian N. Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. Magn Reson Imaging 2004;22:625- 629.
38. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983;40:138-142.
39. Abdul-Rahman A, Agardh CD, Siesjo BK. Local cerebral blood flow in the rat during severe hypoglycemia, and in the recovery period following glucose injection. Acta Physiol Scand 1980;109:307-314.
40. Tallroth G, Ryding E, Agardh CD. Regional cerebral blood flow in normal man during insulin-induced hypoglycemia and in the recovery period following glucose infusion. Metabolism 1992;41:717-721.
41. Chiu NT, Huang CC, Chang YC, Lin CH, Yao WJ, Yu CY. Technetium-99m-HMPAO brain SPECT in neonates with hypoglycaemic en cephalopathy. J Nucl Med 1998;39:1711- 1713.
42. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW. Human brain infarction: proton MR spectroscopy. Radiology 1992; 183:711-718.
43. Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181:173- 181.
44. Cheitlin MD, Hutter AM Jr, Brindis RG, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol 1999;33:273-282.
45. Vredenbregt MJ, Blok-Tip L, Hoogerbrugge R, Barends DM, de Kaste D. Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. J Pharm Biomed Anal 2006;40:840- 849.
46. Wai CT, Tan BH, Chan CL, et al. Druginduced liver injury at an Asian center: a prospective study. Liver Int 2007;27:465-474.
47. HSA alerts on wider spread of harmful illegal health products. Health Sciences Authority of Singapore. http://www.hsa.gov.sg/publish/etc/medialib/hsa- library/corporate/pr20072009.Par.50960.File.tmp/PressRelease- HSAAlertsOnWiderSpreadOfHarmful IllegalHealthProducts-11Apr2008.pdf. Published April 11, 2008. Accessed May 5, 2008.